| 1 |
Heisser T, Cardoso R, Niedermaier T, Hoffmeister M, Brenner H. Making colonoscopy-based screening more efficient: A "gateopener" approach. Int J Cancer 2023;152:952-61. [PMID: 36214791 DOI: 10.1002/ijc.34317] [Reference Citation Analysis]
|
| 2 |
Somsouk M, Lee B, Potter MB. Opportunity and promise of stool-based organized colorectal cancer screening programs. Techniques and Innovations in Gastrointestinal Endoscopy 2023. [DOI: 10.1016/j.tige.2023.02.003] [Reference Citation Analysis]
|
| 3 |
Malagón M, Alwers E, Oliver L, Ramió-pujol S, Sánchez-vizcaino M, Amoedo J, de Cambra S, Serra-pagès M, Castells A, Aldeguer X, Garcia-gil J, Brenner H. Clinical Performance Study of a Fecal Bacterial Signature Test for Colorectal Cancer Screening.. [DOI: 10.21203/rs.3.rs-2482870/v1] [Reference Citation Analysis]
|
| 4 |
Sung JJY, Chiu HM, Lieberman D, Kuipers EJ, Rutter MD, Macrae F, Yeoh KG, Ang TL, Chong VH, John S, Li J, Wu K, Ng SSM, Makharia GK, Abdullah M, Kobayashi N, Sekiguchi M, Byeon JS, Kim HS, Parry S, Cabral-Prodigalidad PAI, Wu DC, Khomvilai S, Lui RN, Wong S, Lin YM, Dekker E. Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance. Gut 2022;71:2152-66. [PMID: 36002247 DOI: 10.1136/gutjnl-2022-327377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Sali L, Ventura L, Mascalchi M, Falchini M, Mallardi B, Carozzi F, Milani S, Zappa M, Grazzini G, Mantellini P. Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial. Lancet Gastroenterol Hepatol 2022;7:1016-23. [PMID: 36116454 DOI: 10.1016/S2468-1253(22)00269-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 6 |
Kværner AS, Birkeland E, Vinberg E, Hoff G, Hjartåker A, Rounge TB, Berstad P. Associations of red and processed meat intake with screen-detected colorectal lesions. Br J Nutr 2022;:1-11. [PMID: 36069337 DOI: 10.1017/S0007114522002860] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Niedermaier T, Alwers E, Chen X, Heisser T, Hoffmeister M, Brenner H. A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment.. [DOI: 10.1101/2022.07.22.22277924] [Reference Citation Analysis]
|
| 8 |
Grobbee EJ, Wisse PHA, Schreuders EH, van Roon A, van Dam L, Zauber AG, Lansdorp-Vogelaar I, Bramer W, Berhane S, Deeks JJ, Steyerberg EW, van Leerdam ME, Spaander MC, Kuipers EJ. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Cochrane Database Syst Rev 2022;6:CD009276. [PMID: 35665911 DOI: 10.1002/14651858.CD009276.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Bhardwaj M, Schrotz-King P, Brenner H. Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze-Thaw Cycles Apart. Life (Basel) 2022;12. [PMID: 35330110 DOI: 10.3390/life12030359] [Reference Citation Analysis]
|
| 10 |
Iwasaki H, Shimura T, Kitagawa M, Yamada T, Nishigaki R, Fukusada S, Okuda Y, Katano T, Horike SI, Kataoka H. A Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer. Cancers (Basel) 2022;14:461. [PMID: 35053622 DOI: 10.3390/cancers14020461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Mandrik O, Thomas C, Whyte S, Chilcott J. Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions. Pharmacoeconomics 2022. [PMID: 34993914 DOI: 10.1007/s40273-021-01125-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Zhou RC, Wang PZ, Li YY, Zhang Y, Ma MJ, Meng FY, Liu C, Yang XY, Lv M, Zuo XL, Li YQ. Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study. Front Med (Lausanne) 2021;8:762560. [PMID: 34765625 DOI: 10.3389/fmed.2021.762560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Brenner H, Hoffmeister M. Striving to optimize colorectal cancer prevention. Nat Rev Gastroenterol Hepatol 2021;18:677-8. [PMID: 34282305 DOI: 10.1038/s41575-021-00494-6] [Reference Citation Analysis]
|
| 14 |
Heisser T, Cardoso R, Niedermaier T, Hoffmeister M, Brenner H. Making colonoscopy-based screening more efficient: a ‘gateopener’ approach.. [DOI: 10.1101/2021.09.14.21263600] [Reference Citation Analysis]
|
| 15 |
Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ 2021;374:n1855. [PMID: 34526356 DOI: 10.1136/bmj.n1855] [Cited by in Crossref: 64] [Cited by in F6Publishing: 30] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 16 |
Maclean W, Mackenzie P, Limb C, Zahoor Z, Whyte MB, Rockall T, Benton SC, Jourdan I. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients. Colorectal Dis 2021;23:2376-86. [PMID: 34157205 DOI: 10.1111/codi.15780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Chen H, Wang L, Lu M, Zhu C, Zhu Y, Ma W, Chen X, Du L, Chen W. Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis. Chin J Cancer Res 2021;33:512-21. [PMID: 34584376 DOI: 10.21147/j.issn.1000-9604.2021.04.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Lu M, Wang L, Zhang Y, Liu C, Lu B, Du L, Liao X, Dong D, Wei D, Gao Y, Shi J, Ren J, Chen H, Dai M. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening. Clin Transl Gastroenterol 2021;12:e00398. [PMID: 34397041 DOI: 10.14309/ctg.0000000000000398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Schöttker B, Gào X, Jansen EH, Brenner H. Associations of Human Colorectal Adenoma with Serum Biomarkers of Body Iron Stores, Inflammation and Antioxidant Protein Thiols. Antioxidants (Basel) 2021;10:1195. [PMID: 34439443 DOI: 10.3390/antiox10081195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Gies A, Niedermaier T, Alwers E, Hielscher T, Weigl K, Heisser T, Schrotz-King P, Hoffmeister M, Brenner H. Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening. Cancers (Basel) 2021;13:3574. [PMID: 34298786 DOI: 10.3390/cancers13143574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Kortlever TL, van der Vlugt M, Dekker E, Bossuyt PMM. Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening. Prev Med Rep 2021;23:101447. [PMID: 34168954 DOI: 10.1016/j.pmedr.2021.101447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Lu M, Zhang YH, Lu B, Cai J, Liu CC, Chen HD, Dai M. Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm. Chin Med J (Engl) 2021;134:1335-44. [PMID: 34039863 DOI: 10.1097/CM9.0000000000001524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;325:1978-98. [PMID: 34003220 DOI: 10.1001/jama.2021.4417] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 53.5] [Reference Citation Analysis]
|
| 24 |
Niedermaier T, Amitay EL, Gies A, Weigl K, Hoffmeister M, Brenner H. Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice. Clin Transl Gastroenterol 2020;11:e00169. [PMID: 32352678 DOI: 10.14309/ctg.0000000000000169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 25 |
Gies A, Niedermaier T, Weigl K, Schrotz-King P, Hoffmeister M, Brenner H. Effect of long-term frozen storage and thawing of stool samples on faecal haemoglobin concentration and diagnostic performance of faecal immunochemical tests. Clin Chem Lab Med 2020;58:390-8. [PMID: 31655793 DOI: 10.1515/cclm-2019-0878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Ferlizza E, Solmi R, Sgarzi M, Ricciardiello L, Lauriola M. The Roadmap of Colorectal Cancer Screening. Cancers (Basel) 2021;13:1101. [PMID: 33806465 DOI: 10.3390/cancers13051101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
Benton SC, Symonds E, Djedovic N, Jones S, Deprez L, Kocna P, Maria Auge J; International Federation of Clinical Chemistry Faecal Immunochemical Test Working Group (IFCC FIT-WG). Faecal immunochemical tests for haemoglobin: Analytical challenges and potential solutions. Clin Chim Acta 2021;517:60-5. [PMID: 33571484 DOI: 10.1016/j.cca.2021.01.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Gies A, Niedermaier T, Gruner LF, Heisser T, Schrotz-King P, Brenner H. Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers. Cancers (Basel) 2021;13:644. [PMID: 33562775 DOI: 10.3390/cancers13040644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Sandhu K, Naik S, Ayling RM. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children. Ann Clin Biochem 2021;58:230-5. [PMID: 33412889 DOI: 10.1177/0004563221989359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Bhardwaj M, Terzer T, Schrotz-King P, Brenner H. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer. Int J Mol Sci 2021;22:1189. [PMID: 33530402 DOI: 10.3390/ijms22031189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
O'Driscoll S, Carroll M, Maclean W, Piggott C, Jourdan I, Benton SC. Assessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin. Ann Clin Biochem 2021;58:181-9. [PMID: 33353372 DOI: 10.1177/0004563220986595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Steel MJ, Bukhari H, Gentile L, Telford J, Schaeffer DF. Colorectal adenocarcinomas diagnosed following a negative faecal immunochemical test show high-risk pathological features in a colon screening programme. Histopathology 2021;78:710-6. [PMID: 33037645 DOI: 10.1111/his.14278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 33 |
Niedermaier T, Tikk K, Gies A, Bieck S, Brenner H. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location. Clin Gastroenterol Hepatol 2020;18:2920-2928.e6. [PMID: 31988043 DOI: 10.1016/j.cgh.2020.01.025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 34 |
Högberg C, Gunnarsson U, Jansson S, Thulesius H, Cronberg O, Lilja M. Diagnosing colorectal cancer in primary care: cohort study in Sweden of qualitative faecal immunochemical tests, haemoglobin levels, and platelet counts. Br J Gen Pract 2020;70:e843-51. [PMID: 33139332 DOI: 10.3399/bjgp20X713465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 35 |
Zhou Z, Ge S, Li Y, Ma W, Liu Y, Hu S, Zhang R, Ma Y, Du K, Syed A, Chen P. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer. Front Microbiol 2020;11:596027. [PMID: 33329482 DOI: 10.3389/fmicb.2020.596027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 36 |
Chapman CJ, Banerjea A, Humes DJ, Allen J, Oliver S, Ford A, Hardy K, Djedovic N, Logan RF, Morling JR. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer. Clin Chem Lab Med 2020:cclm-2020-1170. [PMID: 33112776 DOI: 10.1515/cclm-2020-1170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 37 |
Mattar R, Marques SB, Minata MK, Silva-Etto JMKD, Sakai P, DE Moura EGH. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION. Arq Gastroenterol 2020;57:316-22. [PMID: 32935747 DOI: 10.1590/S0004-2803.202000000-58] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Robertson DJ, Selby K. Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test. Gastrointest Endosc Clin N Am 2020;30:511-26. [PMID: 32439085 DOI: 10.1016/j.giec.2020.02.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 39 |
Peng L, Balavarca Y, Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests. Am J Gastroenterol 2020;115:1110-6. [PMID: 32618662 DOI: 10.14309/ajg.0000000000000579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 40 |
Liu L, He Q, Li Y, Zhang B, Sun X, Shan J, Pan B, Zhang T, Zhao Z, Song X, Guo Y. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer. Clin Chim Acta 2020;509:36-42. [PMID: 32502495 DOI: 10.1016/j.cca.2020.05.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Atkin W, Cross AJ, Kralj-Hans I, MacRae E, Piggott C, Pearson S, Wooldrage K, Brown J, Lucas F, Prendergast A, Marchevsky N, Patel B, Pack K, Howe R, Skrobanski H, Kerrison R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran S. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Health Technol Assess 2019;23:1-84. [PMID: 30618357 DOI: 10.3310/hta23010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 42 |
Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, José Lozano J, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clin Transl Gastroenterol 2019;10:e00003. [PMID: 30702491 DOI: 10.14309/ctg.0000000000000003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 43 |
Bhardwaj M, Weigl K, Tikk K, Holland-Letz T, Schrotz-King P, Borchers CH, Brenner H. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. Eur J Cancer 2020;127:30-40. [PMID: 31972396 DOI: 10.1016/j.ejca.2019.11.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 44 |
Niedermaier T, Balavarca Y, Brenner H. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis. Am J Gastroenterol 2020;115:56-69. [PMID: 31850933 DOI: 10.14309/ajg.0000000000000465] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 45 |
Fraser CG, Benton SC. Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations. Clin Chem Lab Med 2019;57:611-6. [PMID: 29995629 DOI: 10.1515/cclm-2018-0464] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 46 |
Mu J, Huang Y, Cai S, Li Q, Song Y, Yuan Y, Zhang S, Zheng S. Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia. Clin Chim Acta 2020;501:42-7. [PMID: 31816287 DOI: 10.1016/j.cca.2019.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Selby K, Levine EH, Doan C, Gies A, Brenner H, Quesenberry C, Lee JK, Corley DA. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis. Gastroenterology 2019;157:1494-505. [PMID: 31472152 DOI: 10.1053/j.gastro.2019.08.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 48 |
Delfin-riela T, Rossotti MA, Echaides C, González-sapienza G. A nanobody-based test for highly sensitive detection of hemoglobin in fecal samples. Anal Bioanal Chem 2020;412:389-96. [DOI: 10.1007/s00216-019-02246-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 49 |
Bhardwaj M, Weigl K, Tikk K, Benner A, Schrotz-King P, Brenner H. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer. Mol Oncol 2020;14:8-21. [PMID: 31652396 DOI: 10.1002/1878-0261.12591] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 50 |
Kramer J, Früh U. Prävention von Darmkrebserkrankungen. Präv Gesundheitsf 2019;14:407-413. [DOI: 10.1007/s11553-019-00705-8] [Reference Citation Analysis]
|
| 51 |
Brenner H, Gies A, Selby K. Overestimated Sensitivity of Fecal Immunochemical Tests in Screening Cohorts With Registry-Based Follow-up. Am J Gastroenterol 2019;114:1795-801. [PMID: 31658130 DOI: 10.14309/ajg.0000000000000412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 52 |
Bhardwaj M, Gies A, Weigl K, Tikk K, Benner A, Schrotz-King P, Borchers CH, Brenner H. Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer. Cancers (Basel). 2019;11. [PMID: 31557860 DOI: 10.3390/cancers11101426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 53 |
Cross AJ, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A, Patel B, Pack K, Howe R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran SP, Atkin WS. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study. Gut 2019;68:1642-52. [PMID: 30538097 DOI: 10.1136/gutjnl-2018-317297] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 54 |
Ransohoff JR, Melanson SEF. What's New in Point-of-Care Testing? Point of Care 2019;18:92-98. [DOI: 10.1097/poc.0000000000000193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 55 |
Faivre J. Screening del cancro del colon-retto. EMC - AKOS - Trattato di Medicina 2019;21:1-9. [DOI: 10.1016/s1634-7358(19)42565-5] [Reference Citation Analysis]
|
| 56 |
Gies A, Gruner LF, Schrotz-King P, Brenner H. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests. Clin Gastroenterol Hepatol 2019;17:1829-1839.e4. [PMID: 30851476 DOI: 10.1016/j.cgh.2019.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Faivre J. Detección sistemática del cáncer colorrectal. EMC - Tratado de Medicina 2019;23:1-9. [DOI: 10.1016/s1636-5410(19)42731-1] [Reference Citation Analysis]
|
| 58 |
Brenner H, Gies A. Immunologische Stuhlbluttests – welche Verbesserungen gegenüber dem guajakbasierten Test? best practice onkologie 2019;14:190-194. [DOI: 10.1007/s11654-019-0145-7] [Reference Citation Analysis]
|
| 59 |
Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterología y Hepatología (English Edition) 2019;42:263-270. [DOI: 10.1016/j.gastre.2019.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 60 |
Gross M, Holinski-feder E. Darmkrebs: Vorsorge und Früherkennung neu geregelt. MMW - Fortschritte der Medizin 2019;161:43-48. [DOI: 10.1007/s15006-019-0407-x] [Reference Citation Analysis]
|
| 61 |
Yuan SY, Wu W, Fu J, Lang YX, Li JC, Guo Y, Wang YN, Qian JM, Li JN. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening. J Dig Dis 2019;20:78-82. [PMID: 30714346 DOI: 10.1111/1751-2980.12711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 62 |
Brenner H, Gies A. Immunologische Stuhlbluttests – welche Verbesserungen gegenüber dem guajakbasierten Test? Gastroenterologe 2019;14:6-13. [DOI: 10.1007/s11377-018-0290-5] [Reference Citation Analysis]
|
| 63 |
Gies A, Cuk K, Schrotz-King P, Brenner H. Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance? Cancers (Basel) 2019;11:E120. [PMID: 30669538 DOI: 10.3390/cancers11010120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 64 |
Amitay EL, Cuk K, Niedermaier T, Weigl K, Brenner H. Factors associated with false‐positive fecal immunochemical tests in a large German colorectal cancer screening study. Int J Cancer 2019;144:2419-27. [DOI: 10.1002/ijc.31972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 65 |
Widlak MM, Neal M, Daulton E, Thomas CL, Tomkins C, Singh B, Harmston C, Wicaksono A, Evans C, Smith S, Savage RS, Covington JA, Arasaradnam RP. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers. Colorectal Dis 2018;20:O335-42. [PMID: 30248228 DOI: 10.1111/codi.14431] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 66 |
Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterol Hepatol 2019;42:263-70. [PMID: 30459060 DOI: 10.1016/j.gastrohep.2018.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 67 |
Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program. Gastroenterology 2018;155:1392-1399.e5. [PMID: 30055170 DOI: 10.1053/j.gastro.2018.07.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 68 |
Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med 2018;169:439-47. [PMID: 30242328 DOI: 10.7326/M18-0244] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 69 |
Godber IM, Benton SC, Fraser CG. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints. J Clin Pathol 2018;71:1041-5. [DOI: 10.1136/jclinpath-2018-205047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 70 |
Niedermaier T, Weigl K, Gies A, Hoffmeister M, Brenner H. Accuracy of a fecal immunochemical test according to outside temperature and travel time. Clin Epidemiol 2018;10:1203-13. [PMID: 30271216 DOI: 10.2147/CLEP.S170169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 71 |
Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med 2018;7:4781-90. [PMID: 30101513 DOI: 10.1002/cam4.1727] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 72 |
Gies A, Cuk K, Schrotz-King P, Brenner H. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening. Clin Transl Gastroenterol 2018;9:168. [PMID: 29976921 DOI: 10.1038/s41424-018-0035-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 73 |
Gies A, Cuk K, Schrotz-King P, Brenner H. Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening. United European Gastroenterol J 2018;6:1223-31. [PMID: 30288285 DOI: 10.1177/2050640618784053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 74 |
Fraser CG. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges. Surgeon. 2018;16:302-308. [PMID: 29548552 DOI: 10.1016/j.surge.2018.01.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 75 |
Leiner P. Neun iFOBT mit vergleichbar guten Ergebnissen. Info Onkol 2018;21:35-35. [DOI: 10.1007/s15004-018-6003-x] [Reference Citation Analysis]
|
